Bulk EV isolated from blood followed by glypican‐1 protein single‐marker analysis can identify early‐stage pancreatic cancer; EV subtypes isolated using antibody cocktails that target EV surface proteins showed higher specificity for pancreatic cancer compared to single‐marker isolation. The gene discussed is PROS1; the disease is pancreatic neoplasm.